Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice.

Capparelli R, Nocerino N, Lanzetta R, Silipo A, Amoresano A, Giangrande C, Becker K, Blaiotta G, Evidente A, Cimmino A, Iannaccone M, Parlato M, Medaglia C, Roperto S, Roperto F, Ramunno L, Iannelli D.

PLoS One. 2010 Jul 22;5(7):e11720. doi: 10.1371/journal.pone.0011720.

2.

Experimental phage therapy against Staphylococcus aureus in mice.

Capparelli R, Parlato M, Borriello G, Salvatore P, Iannelli D.

Antimicrob Agents Chemother. 2007 Aug;51(8):2765-73. Epub 2007 May 21.

3.

Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection.

Pincus NB, Reckhow JD, Saleem D, Jammeh ML, Datta SK, Myles IA.

PLoS One. 2015 Apr 24;10(4):e0124280. doi: 10.1371/journal.pone.0124280. eCollection 2015.

4.

Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.

Daniel A, Euler C, Collin M, Chahales P, Gorelick KJ, Fischetti VA.

Antimicrob Agents Chemother. 2010 Apr;54(4):1603-12. doi: 10.1128/AAC.01625-09. Epub 2010 Jan 19.

5.

LysGH15 reduces the inflammation caused by lethal methicillin-resistant Staphylococcus aureus infection in mice.

Gu J, Zuo J, Lei L, Zhao H, Sun C, Feng X, Du C, Li X, Yang Y, Han W.

Bioeng Bugs. 2011 Mar-Apr;2(2):96-9. doi: 10.4161/bbug.2.2.14883.

PMID:
21636996
6.

Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.

Maira-LitrĂ¡n T, Bentancor LV, Bozkurt-Guzel C, O'Malley JM, Cywes-Bentley C, Pier GB.

PLoS One. 2012;7(9):e43813. doi: 10.1371/journal.pone.0043813. Epub 2012 Sep 6.

7.

Recombinant PBP2a as a vaccine candidate against methicillin-resistant Staphylococcus aureus: Immunogenicity and protectivity.

Haghighat S, Siadat SD, Rezayat Sorkhabadi SM, Akhavan Sepahi A, Sadat SM, Yazdi MH, Mahdavi M.

Microb Pathog. 2017 Jul;108:32-39. doi: 10.1016/j.micpath.2017.04.037. Epub 2017 Apr 28.

PMID:
28457901
8.
9.

Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.

Matsuzaki S, Yasuda M, Nishikawa H, Kuroda M, Ujihara T, Shuin T, Shen Y, Jin Z, Fujimoto S, Nasimuzzaman MD, Wakiguchi H, Sugihara S, Sugiura T, Koda S, Muraoka A, Imai S.

J Infect Dis. 2003 Feb 15;187(4):613-24. Epub 2003 Feb 7.

PMID:
12599078
10.

Isolation and Host Range of Bacteriophage with Lytic Activity against Methicillin-Resistant Staphylococcus aureus and Potential Use as a Fomite Decontaminant.

Jensen KC, Hair BB, Wienclaw TM, Murdock MH, Hatch JB, Trent AT, White TD, Haskell KJ, Berges BK.

PLoS One. 2015 Jul 1;10(7):e0131714. doi: 10.1371/journal.pone.0131714. eCollection 2015.

11.

LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.

Gu J, Xu W, Lei L, Huang J, Feng X, Sun C, Du C, Zuo J, Li Y, Du T, Li L, Han W.

J Clin Microbiol. 2011 Jan;49(1):111-7. doi: 10.1128/JCM.01144-10. Epub 2010 Nov 3.

12.

Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection.

Lee JC, Perez NE, Hopkins CA, Pier GB.

J Infect Dis. 1988 Apr;157(4):723-30.

PMID:
3346565
13.

A novel recombinant vaccine candidate comprising PBP2a and autolysin against Methicillin Resistant Staphylococcus aureus confers protection in the experimental mice.

Haghighat S, Siadat SD, Sorkhabadi SMR, Sepahi AA, Mahdavi M.

Mol Immunol. 2017 Nov;91:1-7. doi: 10.1016/j.molimm.2017.08.013. Epub 2017 Aug 31.

PMID:
28858628
14.

A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.

Nishitani K, Beck CA, Rosenberg AF, Kates SL, Schwarz EM, Daiss JL.

Clin Orthop Relat Res. 2015 Sep;473(9):2735-49. doi: 10.1007/s11999-015-4354-2. Epub 2015 May 27.

15.
16.

The Staphylococcus aureus peptidoglycan protects mice against the pathogen and eradicates experimentally induced infection.

Capparelli R, Nocerino N, Medaglia C, Blaiotta G, Bonelli P, Iannelli D.

PLoS One. 2011;6(12):e28377. doi: 10.1371/journal.pone.0028377. Epub 2011 Dec 1.

17.

Efficacy of lytic Staphylococcus aureus bacteriophage against multidrug-resistant Staphylococcus aureus in mice.

Oduor JM, Onkoba N, Maloba F, Arodi WO, Nyachieo A.

J Infect Dev Ctries. 2016 Nov 24;10(11):1208-1213. doi: 10.3855/jidc.7931.

18.

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

Paul VD, Sundarrajan S, Rajagopalan SS, Hariharan S, Kempashanaiah N, Padmanabhan S, Sriram B, Ramachandran J.

BMC Microbiol. 2011 Aug 31;11:195. doi: 10.1186/1471-2180-11-195.

19.

Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice.

Kim HK, Cheng AG, Kim HY, Missiakas DM, Schneewind O.

J Exp Med. 2010 Aug 30;207(9):1863-70. doi: 10.1084/jem.20092514. Epub 2010 Aug 16.

20.

Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice.

Yi SQ, Zhang XY, Yang YL, Yang Y, Liu SL, Fu L, Yu CM, Chen W.

Microbiol Immunol. 2012 Jun;56(6):406-10. doi: 10.1111/j.1348-0421.2012.00451.x.

Supplemental Content

Support Center